Treace Medical Concepts, Inc. (TMCI) Revenue Growth
Treace Medical Concepts, Inc. (TMCI) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 50.22% |
| 2023-12-31 | 31.92% |
| 2024-12-31 | 11.89% |
| 2025-12-31 | 1.59% |
How TMCI compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| ACHC | Acadia Healthcare Company Inc. | 5.04% |
| ZTS | Zoetis Inc. Class A | 2.28% |
| IART | Integra LifeSciences Holdings Corporation | 1.53% |
| BIO | Bio-Rad Laboratories Inc. Class A | 0.65% |
| NEOG | Neogen Corporation | -2.71% |
These are five companies in the same sector as TMCI with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Treace Medical Concepts, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("TMCI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TMCI | $4.81 | -1.43% | 0.23M |
| 3 | ||||
| 4 | ||||
| 5 |